Federal Register of Legislation - Australian Government

Primary content

PB 46 of 2019 Lists as made
This instrument amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012) to make changes to the pharmaceutical benefits listed on the Pharmaceutical Benefits Scheme and related matters.
Administered by: Health
Registered 28 Jun 2019
Tabling HistoryDate
Tabled HR02-Jul-2019
Tabled Senate02-Jul-2019
To be repealed 17 Sep 2019
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

 

 

 

PB 46 of 2019

 

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2019 (No. 6)

 

National Health Act 1953

________________________________________________________________________

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953.

 

Dated    27 June 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

1          Name of Instrument

(1)          This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2019 (No. 6).

(2)          This Instrument may also be cited as PB 46 of 2019.

2          Commencement

This Instrument commences on 1 July 2019.

3          Amendment of National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)

Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012).


 


Schedule 1     Amendments

[1]             Schedule 1, omit entry for Abciximab

[2]             Schedule 1, entry for Amino acid formula with vitamins and minerals without phenylalanine

                           omit:

 

Oral powder 500 g (XP Maxamaid)

Oral

 

XP Maxamaid

SB

MP NP

C4295

 

8

5

1

 

 

[3]             Schedule 1, entry for Amoxicillin with clavulanic acid in the form Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

                   (a)        omit:

 

 

 

a

Chem mart Amoxycillin and Clavulanic Acid

CH

PDP

C5833 C5894

 

10

0

10

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Amoxycillin and Clavulanic Acid

TW

PDP

C5833 C5894

 

10

0

10

 

 

                   (c)        omit:

 

 

 

a

Chem mart Amoxycillin and Clavulanic Acid

CH

MP NP

C5832 C5893

 

10

1

10

 

 

                   (d)        omit:

 

 

 

a

Terry White Chemists Amoxycillin and Clavulanic Acid

TW

MP NP

C5832 C5893

 

10

1

10

 

 


 

[4]             Schedule 1, entry for Atorvastatin in the form Tablet 10 mg (as calcium)

                   (a)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP NP

 

 

30

5

30

 

 

                   (b)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP

 

P7598

30

11

30

 

 

[5]             Schedule 1, entry for Atorvastatin in the form Tablet 20 mg (as calcium)

                   (a)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP NP

 

 

30

5

30

 

 

                   (b)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP

 

P7598

30

11

30

 

 

[6]             Schedule 1, entry for Atorvastatin in the form Tablet 40 mg (as calcium)

                   (a)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP NP

 

 

30

5

30

 

 

                   (b)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP

 

P7598

30

11

30

 

 

[7]             Schedule 1, entry for Atorvastatin in the form Tablet 80 mg (as calcium)

                   (a)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP NP

 

 

30

5

30

 

 


 

                   (b)        omit:

 

 

 

a

Chem mart Atorvastatin

CH

MP

 

P7598

30

11

30

 

 

[8]             Schedule 1, entry for Bosentan in each of the forms: Tablet 62.5 mg (as monohydrate); and Tablet 125 mg (as monohydrate)

                           omit:

 

 

 

a

Bosentan APOTEX

TX

MP

See Note 3

See Note 3

See Note 3

See Note 3

60

 

D(100)

[9]             Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

                           omit:

 

 

 

a

Chem mart Candesartan

CH

MP NP

 

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan

TW

MP NP

 

 

30

5

30

 

 

[10]           Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

                           omit:

 

 

 

a

Chem mart Candesartan

CH

MP NP

 

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan

TW

MP NP

 

 

30

5

30

 

 

[11]           Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

                           omit:

 

 

 

a

Chem mart Candesartan

CH

MP NP

 

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan

TW

MP NP

 

 

30

5

30

 

 

 


 

[12]           Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

                           omit:

 

 

 

a

Chem mart Candesartan

CH

MP NP

 

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan

TW

MP NP

 

 

30

5

30

 

 

[13]           Schedule 1, entry for Candesartan with hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with
hydrochlorothiazide 12.5 mg

                           omit:

 

 

 

a

Chem mart Candesartan HCTZ 16/12.5

CH

MP NP

C4374

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan HCTZ 16/12.5

TW

MP NP

C4374

 

30

5

30

 

 

[14]           Schedule 1, entry for Candesartan with hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with
hydrochlorothiazide 12.5 mg

                           omit:

 

 

 

a

Chem mart Candesartan HCTZ 32/12.5

CH

MP NP

C4374

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan HCTZ 32/12.5

TW

MP NP

C4374

 

30

5

30

 

 

[15]           Schedule 1, entry for Candesartan with hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with
hydrochlorothiazide 25 mg

                           omit:

 

 

 

a

Chem mart Candesartan HCTZ 32/25

CH

MP NP

C4374

 

30

5

30

 

 

 

 

 

a

Terry White Chemists Candesartan HCTZ 32/25

TW

MP NP

C4374

 

30

5

30

 

 

[16]           Schedule 1, entry for Celecoxib in the form Capsule 100 mg

                   (a)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Celecoxib BTC

JB

MP NP

C4907 C4962

 

60

3

60

 

 

                   (b)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

GenRx Celecoxib

GX

MP NP

C4907 C4962

 

60

3

60

 

 

[17]           Schedule 1, entry for Celecoxib in the form Capsule 200 mg

                   (a)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Celecoxib BTC

JB

MP NP

C4907 C4962

 

30

3

30

 

 

                   (b)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

GenRx Celecoxib

GX

MP NP

C4907 C4962

 

30

3

30

 

 

[18]           Schedule 1, entry for Clarithromycin in the form Tablet 250 mg

                   (a)        omit:

 

 

 

a

Chem mart Clarithromycin

CH

MP NP

 

 

14

1

14

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Clarithromycin

TW

MP NP

 

 

14

1

14

 

 

[19]           Schedule 1, entry for Clopidogrel with aspirin

                   (a)        omit:

 

 

 

a

Chem mart Clopidogrel/Aspirin 75/100

CH

MP NP

C5443 C5488 C5517

 

30

5

30

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Clopidogrel/Aspirin 75/100

TW

MP NP

C5443 C5488 C5517

 

30

5

30

 

 

[20]           Schedule 1, omit entry for Cystine with carbohydrate

[21]           Schedule 1, entry for Fenofibrate in the form Tablet 48 mg [Maximum Quantity: 60; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Fenofibrate Mylan

AF

MP NP

 

 

60

5

60

 

 

[22]           Schedule 1, entry for Fenofibrate in the form Tablet 48 mg [Maximum Quantity: 60; Number of Repeats: 11]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Fenofibrate Mylan

AF

MP

 

P7640

60

11

60

 

 

[23]           Schedule 1, entry for Fenofibrate in the form Tablet 145 mg [Maximum Quantity: 30; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Fenofibrate Mylan

AF

MP NP

 

 

30

5

30

 

 

[24]           Schedule 1, entry for Fenofibrate in the form Tablet 145 mg [Maximum Quantity: 30; Number of Repeats: 11]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”: 

 

 

 

a

Fenofibrate Mylan

AF

MP

 

P7640

30

11

30

 

 

[25]           Schedule 1, entry for Fluorometholone

                           substitute:

Fluorometholone

Eye drops 1 mg per mL, 5 mL

Application to the eye

 

FML Liquifilm

AG

AO

 

 

1

0

1

 

 

 

 

 

 

 

 

MP NP

 

 

1

5

1

 

 

 

Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL

Application to the eye

 

Flarex

NV

AO

 

 

1

0

1

 

 

 

 

 

 

 

 

MP NP

 

 

1

2

1

 

 


 

[26]           Schedule 1, entry for Glatiramer

                           omit:

 

Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe

Injection

 

Copaxone

TB

MP

C6860 C7695

 

28

5

28

 

 

[27]           Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

                   (a)        omit:

 

 

 

a

Chem mart Indapamide SR

CH

MP NP

 

 

90

1

90

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Indapamide SR

TW

MP NP

 

 

90

1

90

 

 

[28]           Schedule 1, entry for Irbesartan in each of the forms: Tablet 75 mg; Tablet 150 mg; and Tablet 300 mg

                           omit:

 

 

 

a

Abisart

AF

MP NP

 

 

30

5

30

 

 

[29]           Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 150 mg-12.5 mg

                           omit:

 

 

 

a

Abisart HCT 150/12.5

AF

MP NP

C4374

 

30

5

30

 

 

[30]           Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-12.5 mg

                           omit:

 

 

 

a

Abisart HCT 300/12.5

AF

MP NP

C4374

 

30

5

30

 

 

[31]           Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-25 mg

                           omit:


 

 

 

 

a

Abisart HCT 300/25

AF

MP NP

C4374

 

30

5

30

 

 

[32]           Schedule 1, entry for Isosorbide mononitrate in the form Tablet 60 mg (sustained release)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

APO-Isosorbide Mononitrate

TX

MP NP

 

 

30

5

30

 

 

[33]           Schedule 1, entry for Isotretinoin

                           insert as first entry:

 

Capsule 5 mg

Oral

 

Oratane

OU

MP

C5224

 

60

3

60

 

 

[34]           Schedule 1, entry for Lercanidipine in each of the forms: Tablet containing lercanidipine hydrochloride 10 mg; and Tablet containing lercanidipine hydrochloride 20 mg

                   (a)        omit:

 

 

 

a

Chem mart Lercanidipine

CH

MP NP

 

 

28

5

28

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Lercanidipine

TW

MP NP

 

 

28

5

28

 

 

[35]           Schedule 1, entry for Letrozole

                   (a)        omit:

 

 

 

a

Chem mart Letrozole

CH

MP NP

C5464

 

30

5

30

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Letrozole

TW

MP NP

C5464

 

30

5

30

 

 

[36]           Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg

                           omit:

 

 

 

a

Formet Aspen 500

RW

MP NP

 

 

100

5

100

 

 

[37]           Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg

                           omit:

 

 

 

a

Formet Aspen 850

RW

MP NP

 

 

60

5

60

 

 

[38]           Schedule 1, entry for Metoprolol succinate in the form Tablet 23.75 mg (controlled release)

                           omit:

 

 

 

a

Toprol-XL 23.75

AP

MP NP

C5324

 

15

0

15

 

 

[39]           Schedule 1, entry for Moclobemide in the form Tablet 150 mg

                           omit:

 

 

 

a

GenRx Moclobemide

GX

MP NP

C5650

 

60

5

60

 

 

[40]           Schedule 1, entry for Montelukast in the form Tablet, chewable, 4 mg (as sodium)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Montelukast APOTEX

GX

MP NP

C6666

 

28

5

28

 

 

[41]           Schedule 1, entry for Montelukast in the form Tablet, chewable, 5 mg (as sodium)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Montelukast APOTEX

GX

MP NP

C6674 C7781

 

28

5

28

 

 

[42]           Schedule 1, entry for Olanzapine in each of the forms: Tablet 2.5 mg; and Tablet 5 mg

                   (a)        omit:

 

 

 

a

Chem mart Olanzapine

CH

MP NP

C5856 C5869

 

28

5

28

 

 


 

                   (b)        omit:

 

 

 

a

Terry White Chemists Olanzapine

TW

MP NP

C5856 C5869

 

28

5

28

 

 

[43]           Schedule 1, entry for Olanzapine in the form Tablet 7.5 mg

                   (a)        omit:

 

 

 

 

Chem mart Olanzapine

CH

MP NP

C5856 C5869

 

28

5

28

 

 

                   (b)        omit:

 

 

 

 

Terry White Chemists Olanzapine

TW

MP NP

C5856 C5869

 

28

5

28

 

 

[44]           Schedule 1, entry for Olanzapine in the form Tablet 10 mg

                   (a)        omit:

 

 

 

a

Chem mart Olanzapine

CH

MP NP

C5856 C5869

 

28

5

28

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Olanzapine

TW

MP NP

C5856 C5869

 

28

5

28

 

 

[45]           Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Olmesartan/Amlodipine 20/5 APOTEX

TX

MP NP

C4373

 

30

5

30

 

 

[46]           Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Olmesartan/Amlodipine 40/5 APOTEX

TX

MP NP

C4373

 

30

5

30

 

 

[47]           Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg
(as besilate)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Olmesartan/Amlodipine 40/10 APOTEX

TX

MP NP

C4373

 

30

5

30

 

 

[48]           Schedule 1, entry for Omeprazole in the form Tablet 20 mg

                   (a)        omit:

 

 

 

 

Chem mart Omeprazole

CH

MP NP

C8774 C8775 C8776 C8780 C8866

P8774 P8775

30

1

30

 

 

                   (b)        omit:

 

 

 

 

Terry White Chemists Omeprazole

TW

MP NP

C8774 C8775 C8776 C8780 C8866

P8774 P8775

30

1

30

 

 

                   (c)        omit:

 

 

 

 

Chem mart Omeprazole

CH

MP NP

C8774 C8775 C8776 C8780 C8866

P8776 P8780 P8866

30

5

30

 

 

                   (d)        omit:

 

 

 

 

Terry White Chemists Omeprazole

TW

MP NP

C8774 C8775 C8776 C8780 C8866

P8776 P8780 P8866

30

5

30

 

 

[49]           Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 100; Number of Repeats: 0]

                   (a)        omit:

 

 

 

a

Generic Health Pty Ltd

GQ

PDP

C5846 C5885

P5846

100

0

100

 

 

                   (b)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Paracetamol Generic Health

GQ

PDP

C5846 C5885

P5846

100

0

100

 

 

[50]           Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 100; Number of Repeats: 1]

                   (a)        omit:

 

 

 

a

Generic Health Pty Ltd

GQ

MP NP

C5835 C5865

P5835

100

1

100

 

 

                   (b)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Paracetamol Generic Health

GQ

MP NP

C5835 C5865

P5835

100

1

100

 

 

[51]           Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 300; Number of Repeats: 0]

                   (a)        omit:

 

 

 

a

Generic Health Pty Ltd

GQ

PDP

C5846 C5885

P5885

300

0

100

 

 

                   (b)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Paracetamol Generic Health

GQ

PDP

C5846 C5885

P5885

300

0

100

 

 

[52]           Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 300; Number of Repeats: 4]

                   (a)        omit:

 

 

 

a

Generic Health Pty Ltd

GQ

MP NP

C5835 C5865

P5865

300

4

100

 

 

                   (b)        insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Paracetamol Generic Health

GQ

MP NP

C5835 C5865

P5865

300

4

100

 

 

[53]           Schedule 1, entry for Pemetrexed in each of the forms: Powder for I.V. infusion 100 mg (as disodium); Powder for I.V. infusion 500 mg (as disodium); and Powder for I.V. infusion 1 g (as disodium)

                           omit from the column headed “Circumstances” (all instances): C4792 C7195

[54]           Schedule 1, after entry for Phenelzine in the form Tablet 15 mg (as sulfate)

                           insert:

 

Tablet 15 mg (as sulfate) (USP)

Oral

 

Nardil

LM

MP

C6236

 

100

1

60

 

 

[55]           Schedule 1, entry for Pioglitazone in each of the forms: Tablet 15 mg (as hydrochloride); Tablet 30 mg (as hydrochloride); and Tablet 45 mg
(as hydrochloride)

                   (a)        omit:

 

 

 

a

Chem mart Pioglitazone

CH

MP NP

C4363 C4364 C4388

 

28

5

28

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Pioglitazone

TW

MP NP

C4363 C4364 C4388

 

28

5

28

 

 

[56]           Schedule 1, omit entry for Pyrimethamine

[57]           Schedule 1, entry for Raloxifene

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Raloxifene GH

GQ

MP NP

C6314

 

28

5

28

 

 

[58]           Schedule 1, entry for Ramipril in each of the forms: Capsule 2.5 mg; and Capsule 5 mg

                           omit:

 

 

 

 

Chem mart Ramipril

CH

MP NP

 

 

30

5

30

 

 

 

 

 

 

Terry White Chemists Ramipril

TW

MP NP

 

 

30

5

30

 

 

[59]           Schedule 1, entry for Ramipril in the form Capsule 10 mg

                   (a)        omit:

 

 

 

 

Chem mart Ramipril

CH

MP NP

 

 

30

5

30

 

 

                   (b)        omit:

 

 

 

 

Terry White Chemists Ramipril

TW

MP NP

 

 

30

5

30

 

 

[60]           Schedule 1, entry for Ramipril in each of the forms: Tablet 2.5 mg; and Tablet 5 mg

                   (a)        omit:

 

 

 

 

Chem mart Ramipril

CH

MP NP

 

 

30

5

30

 

 

                   (b)        omit:

 

 

 

 

Terry White Chemists Ramipril

TW

MP NP

 

 

30

5

30

 

 

[61]           Schedule 1, entry for Ritonavir

                           omit:

 

Oral solution 600 mg per 7.5 mL (80 mg per mL), 90 mL

Oral

 

Norvir

VE

MP

C4454 C4512

 

10

5

1

 

D(100)

[62]           Schedule 1, omit entry for Rosiglitazone with metformin

[63]           Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate)

                   (a)        omit:

 

 

 

 

Chem mart Sumatriptan

CH

MP NP

C5259

 

4

5

2

 

 

 

 

 

 

 

 

MP NP

C5259

 

4

5

4

 

 

                   (b)        omit:

 

 

 

 

Terry White Chemists Sumatriptan

TW

MP NP

C5259

 

4

5

2

 

 

 

 

 

 

 

 

MP NP

C5259

 

4

5

4

 

 

[64]           Schedule 1, entry for Temozolomide in the form Capsule 5 mg [Maximum Quantity: 5; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

 

5

5

5

 

 

[65]           Schedule 1, entry for Temozolomide in the form Capsule 5 mg [Maximum Quantity: 15; Number of Repeats: 2]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

P4897

15

2

5

 

 

[66]           Schedule 1, entry for Temozolomide in the form Capsule 20 mg [Maximum Quantity: 5; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

 

5

5

5

 

 

[67]           Schedule 1, entry for Temozolomide in the form Capsule 20 mg [Maximum Quantity: 15; Number of Repeats: 2]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

P4897

15

2

5

 

 

[68]           Schedule 1, entry for Temozolomide in the form Capsule 100 mg [Maximum Quantity: 5; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

 

5

5

5

 

 

[69]           Schedule 1, entry for Temozolomide in the form Capsule 100 mg [Maximum Quantity: 15; Number of Repeats: 2]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

P4897

15

2

5

 

 

[70]           Schedule 1, entry for Temozolomide in the form Capsule 140 mg [Maximum Quantity: 5; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

 

5

5

5

 

 

[71]           Schedule 1, entry for Temozolomide in the form Capsule 140 mg [Maximum Quantity: 15; Number of Repeats: 2]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

P4897

15

2

5

 

 


 

[72]           Schedule 1, entry for Temozolomide in the form Capsule 180 mg [Maximum Quantity: 5; Number of Repeats: 5]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

 

5

5

5

 

 

[73]           Schedule 1, entry for Temozolomide in the form Capsule 180 mg [Maximum Quantity: 15; Number of Repeats: 2]

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

P4897

15

2

5

 

 

[74]           Schedule 1, entry for Temozolomide in the form Capsule 250 mg

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Temozolomide Juno

JX

MP

 

 

5

5

5

 

 

[75]           Schedule 1, entry for Tirofiban

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Tirofiban Juno

JU

MP NP

C5691 C5782 C5809

 

1

2

1

 

 

[76]           Schedule 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride)

                   (a)        omit:

 

 

 

a

Chem mart Valaciclovir

CH

MP NP

C5940 C5961 C5962 C5968

P5940 P5961

30

5

30

 

 

                   (b)        omit:

 

 

 

a

Terry White Chemists Valaciclovir

TW

MP NP

C5940 C5961 C5962 C5968

P5940 P5961

30

5

30

 

 

                   (c)        omit:

 

 

 

a

Chem mart Valaciclovir

CH

MP NP

C5940 C5961 C5962 C5968

P5962 P5968

42

0

42

 

 

 

 

 

a

Terry White Chemists Valaciclovir

TW

MP NP

C5940 C5961 C5962 C5968

P5962 P5968

42

0

42

 

 

[77]           Schedule 1, entry for Ziprasidone in each of the forms: Capsule 20 mg (as hydrochloride); Capsule 40 mg (as hydrochloride); Capsule 60 mg (as hydrochloride); and Capsule 80 mg (as hydrochloride)

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

a

Ziprasidone GH

GQ

MP NP

C4246 C5742

 

60

5

60

 

 

[78]           Schedule 1, entry for Zoledronic acid in the form Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

                           insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

 

DEZTRON

DZ

MP

C5605 C5606 C5676 C5677 C5703 C5704 C5735 C5736

 

1

11

1

 

PB(100)

[79]           Schedule 3, after details relevant to Responsible Person code OS

insert:

OU

Oraderm Pharmaceuticals Pty Ltd

50 612 828 618

[80]           Schedule 4, Part 1, omit entry for Abciximab

[81]           Schedule 4, Part 1, omit entry for Cystine with carbohydrate

[82]           Schedule 4, Part 1, omit entry for Pemetrexed

[83]           Schedule 4, Part 1, omit entry for Rosiglitazone with metformin

[84]           Schedule 5, entry for Olanzapine in the form Tablet 7.5 mg [GRP-15884]

                   (a)        omit from the column headed “Brand”: Chem mart Olanzapine

                   (b)        omit from the column headed “Brand”: Terry White Chemists Olanzapine

[85]           Schedule 5, entry for Omeprazole in the form Tablet 20 mg [GRP-14650]

                   (a)        omit from the column headed “Brand”: Chem mart Omeprazole

                   (b)        omit from the column headed “Brand”: Terry White Chemists Omeprazole


 

[86]           Schedule 5, after entry for Perindopril with indapamide [GRP-15765]

                           insert:

Phenelzine

GRP-23097

Tablet 15 mg (as sulfate)

Oral

Nardil

 

 

Tablet 15 mg (as sulfate) (USP)

Oral

Nardil

[87]           Schedule 5, entry for Ramipril in each of the forms: Capsule 5 mg; and Tablet 5 mg [GRP-15424]

                   (a)        omit from the column headed “Brand”: Chem mart Ramipril

                   (b)        omit from the column headed “Brand”: Terry White Chemists Ramipril

[88]           Schedule 5, entry for Ramipril in the form Capsule 10 mg [GRP-15431]

                   (a)        omit from the column headed “Brand”: Chem mart Ramipril

                   (b)        omit from the column headed “Brand”: Terry White Chemists Ramipril

[89]           Schedule 5, entry for Ramipril in each of the forms: Capsule 2.5 mg; and Tablet 2.5 mg [GRP-15769]

                   (a)        omit from the column headed “Brand”: Chem mart Ramipril

                   (b)        omit from the column headed “Brand”: Terry White Chemists Ramipril

[90]           Schedule 5, entry for Sumatriptan

                           substitute:

Sumatriptan

GRP-15928

Tablet (fast disintegrating) 50 mg (as succinate)

Oral

Imigran FDT

 

 

Tablet 50 mg (as succinate)

Oral

APO-Sumatriptan
Imigran
Iptam
Pharmacor Sumatriptan 50
Sumatran
Sumatriptan AN
Sumatriptan Sandoz
Sumatriptan generichealth

[91]           Schedule 5, entry for Zoledronic acid in the form Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL [GRP-17614]

                           insert in alphabetical order in the column headed “Brand”: DEZTRON